| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6015479 | Epilepsy Research | 2014 | 10 Pages |
Abstract
This pilot study has shown mild benefits of verapamil use in comparison to placebo as an add-on therapy for a group of non-selected patients with refractory epilepsy. A partial response in a subset of patients was seen. No significant safety problems happened, but adjustments on AEDs may be required during verapamil use.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Felippe Borlot, Robert G. Wither, Anfal Ali, Nicky Wu, Flavia Verocai, Danielle M. Andrade,